[HTML][HTML] Autophagy and EMT in cancer and metastasis: Who controls whom?

R Gundamaraju, W Lu, MK Paul, NK Jha… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Metastasis consists of hallmark events, including Epithelial-Mesenchymal Transition (EMT),
angiogenesis, initiation of inflammatory tumor microenvironment, and malfunctions in …

Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets

B Ballester, J Milara, J Cortijo - International journal of molecular sciences, 2019 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pulmonary
disease with a median survival of 2–4 years after diagnosis. A significant number of IPF …

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

C Butts, MA Socinski, PL Mitchell, N Thatcher… - The lancet …, 2014 - thelancet.com
Background Effective maintenance therapies after chemoradiotherapy for lung cancer are
lacking. Our aim was to investigate whether the MUC1 antigen-specific cancer …

Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion

P Paone, F Suriano, C Jian, K Korpela… - Gut …, 2022 - Taylor & Francis
Obesity is a major risk factor for the development of type 2 diabetes and cardiovascular
diseases, and gut microbiota plays a key role in influencing the host energy homeostasis …

A bacteriophages journey through the human body

JJ Barr - Immunological Reviews, 2017 - Wiley Online Library
The human body is colonized by a diverse collective of microorganisms, including bacteria,
fungi, protozoa and viruses. The smallest entity of this microbial conglomerate are the …

[HTML][HTML] Membrane-active host defense peptides–challenges and perspectives for the development of novel anticancer drugs

S Riedl, D Zweytick, K Lohner - Chemistry and physics of lipids, 2011 - Elsevier
Although much progress has been achieved in the development of cancer therapies in
recent decades, problems continue to arise particularly with respect to chemotherapy due to …

Mucin-type O-glycans and their roles in intestinal homeostasis

KSB Bergstrom, L Xia - Glycobiology, 2013 - academic.oup.com
Mucin-type O-glycans are the primary constituents of mucins that are expressed on various
mucosal sites of the body, especially the bacteria-laden intestinal tract. Mucins are the main …

Mucins in pancreatic cancer and its microenvironment

S Kaur, S Kumar, N Momi, AR Sasson… - Nature reviews …, 2013 - nature.com
Pancreatic cancer remains a lethal malignancy with poor prognosis owing to therapeutic
resistance, frequent recurrence and the absence of treatment strategies that specifically …

The use of therapeutic peptides to target and to kill cancer cells

RJ Boohaker, MW Lee, P Vishnubhotla… - Current medicinal …, 2012 - ingentaconnect.com
Peptide therapeutics is a promising field for emerging anti-cancer agents. Benefits include
the ease and rapid synthesis of peptides and capacity for modifications. An existing and vast …

MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma

LA Doyle, E Möller, P Dal Cin… - The American journal …, 2011 - journals.lww.com
Low-grade fibromyxoid sarcoma (LGFMS) is a distinctive fibroblastic neoplasm that is
characterized by alternating collagenous and myxoid areas, deceptively bland spindle cell …